CAH

Cardinal Health
D

CAH

Arincen75/100B

Cardinal Health EPS (earnings per share) 1986–2027

Cardinal Health's diluted EPS in Q1 FY2027, the three months to 30 September 2026, was 2.38 USD, up 26.6% on the same quarter a year before. Cardinal Health's diluted earnings per share over the last twelve months were 7.73 USD, up 16.6% on the twelve months before. In fiscal year 2026 they were 7.23 USD, up 12.1% on the year before.

Last updated 7 Nov 2026 · Next report 4 Feb 2027

EPS

Growth

Fiscal yearPeriod endingEPSGrowthEPS (basic)
TTM30 Sept 20267.73+16.59%7.77
FY202630 Jun 20267.23+12.09%7.27
FY202530 Jun 20256.45+86.96%6.48
FY202430 Jun 20243.45+173.81%3.48
FY202330 Jun 20231.26—1.26
FY202230 Jun 2022-3.34-260.58%-3.34
FY202130 Jun 20212.08—2.09
FY202030 Jun 2020-12.60-378.15%-12.60
FY201930 Jun 20194.53+459.26%4.54
FY201830 Jun 20180.81-79.90%0.82
FY201730 Jun 20174.03-6.71%4.06
FY201630 Jun 20164.32+19.34%4.36
FY201530 Jun 20153.62+7.10%3.66
FY201430 Jun 20143.38+248.45%3.42
FY201330 Jun 20130.97-68.30%0.98
FY201230 Jun 20123.06+12.50%3.10
FY201130 Jun 20112.72+53.67%2.75
FY201030 Jun 20101.77-44.34%1.79
FY200930 Jun 20093.18-10.92%3.22
FY200830 Jun 20083.57-25.16%3.63
FY200730 Jun 20074.77+104.72%4.89
FY200630 Jun 20062.33-3.32%2.38
FY200530 Jun 20052.41-28.06%2.44
FY200430 Jun 20043.35+10.56%3.39
FY200330 Jun 20033.03+30.04%3.08
FY200230 Jun 20022.33+25.95%2.37
FY200130 Jun 20011.85+17.09%1.90
FY200030 Jun 20001.58+41.07%1.61
FY199930 Jun 19991.12+9.80%1.15
FY199830 Jun 19981.02+24.39%1.05
FY199730 Jun 19970.82+60.78%0.84
FY199630 Jun 19960.51-17.74%0.51
FY199530 Jun 19950.62+210.00%0.63
FY199430 Jun 19940.20-48.72%0.20
FY199330 Jun 19930.39+30.00%0.42
FY199230 Jun 19920.30+25.00%0.31
FY199130 Jun 19910.24+26.32%0.25
FY199030 Jun 19900.19+18.75%0.19
FY198931 Mar 19890.16+23.08%0.19
FY198831 Mar 19880.13+18.18%0.15
FY198731 Mar 19870.11-8.33%0.13
FY198631 Mar 19860.12—0.14

Figures in USD. Shares and EPS are adjusted for stock splits. Quarterly growth is on the same quarter a year before; TTM is the last four quarters.

See also:Revenue,Net income,Shares outstanding,Operating income,Cash on hand,Total debt,Free cash flow,Stock buybacks,Income statement

Common questions about Cardinal Health's EPS

Source: Financial Modeling Prep

Risk Disclosure: Trading in financial instruments involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks. Never invest money you cannot afford to lose, and carefully assess the suitability of complex products such as CFDs and derivatives in light of your financial situation. Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed. Arincen would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes.

Arincen and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website. It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Arincen and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website. Arincen may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.

© 2026 - Arincen L.L.C-FZ - License No. 2420098.01. All Rights Reserved.